Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 2
Review
Emerging oral immunomodulating agents – focus on teriflunomide for the treatment of multiple sclerosis
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,596 | Dovepress* | 8,596+ | 2,695 | 11,291 | |
Totals | 8,596 | 2,695 | 11,291 | ||
*Since 13 March 2012 +Since July 2016 |
View citations on Google Scholar